WebDisclosure WebDisclosure
Basculer en Français
10031 Companies
204052 Keywords
134442 Articles
108254 Press releases
Headlines Articles Press releases HKeyBio Remove
  1. Home
  2. Companies
  3. HKeyBio
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 01/27/2026 at 09:40, 1 month 17 days ago

    HKeyBio Unveils HKEY-AIRx™1.0 for Asthma and Allergy Drug Development

    Biotech Drug Development Asthma HKeyBio Translational Strategy
  • BRIEF

    published on 01/27/2026 at 09:40, 1 month 17 days ago

    HKeyBio dévoile HKEY-AIRx™ 1.0 pour le développement de médicaments contre l'asthme et les allergies

    Biotechnologie Développement De Médicaments Asthme HKeyBio Stratégie Translationnelle
  • PRESS RELEASE

    published on 01/27/2026 at 09:35, 1 month 17 days ago

    Asthma and Allergy Drug Development Is Failing Too Often--A Translational Reset Is Needed: HKEY-AIRx™1.0

    HKeyBio introduces HKEY-AIRx™1.0, a preclinical strategy to enhance asthma and allergy drug development success by aligning disease endotypes, patient heterogeneity, and translational endpoints
    Drug Development Asthma HKeyBio Allergy Translational Reset
    Logo of HKeyBio
Accesswire
  • Published on 03/13/2026 at 14:00, 1 hour 38 minutes ago

    CCL Industries Signs Agreement to Acquire Sleever International

  • Published on 03/13/2026 at 13:30, 2 hours 8 minutes ago

    Zentek Ltd. Receives Favorable Judgment in Long-Standing Litigation

  • Published on 03/13/2026 at 13:30, 2 hours 8 minutes ago

    Sky Gold Engages Drill Company for Upcoming Program on Its Evening Star Property, Walker Lane Trend, Nevada

  • Published on 03/13/2026 at 12:30, 3 hours 8 minutes ago

    Hans Vestberg Co-Founds Next Phase of US Data Centers Inc. with Digi Power X to Deploy Modular AI Infrastructure at Scale

  • Published on 03/13/2026 at 12:30, 3 hours 8 minutes ago

    Battery X Metals Announces Equity Incentive Grants

View all ACCESSWIRE
EQS Group
  • Published on 03/13/2026 at 15:22, 16 minutes ago

    Edison issues report on Finsbury Growth & Income Trust (FGT)

  • Published on 03/13/2026 at 15:16, 22 minutes ago

    EQS-Adhoc: Fraport AG Frankfurt Airport Services Worldwide: Dividend Forecast

  • Published on 03/13/2026 at 15:15, 23 minutes ago

    EQS-Adhoc: Finexity AG: FINEXITY AG publishes preliminary financial results for 2025 and provides outlook for fiscal year 2026

  • Published on 03/13/2026 at 14:58, 40 minutes ago

    The Law Debenture Corporation (LWDB)

  • Published on 03/13/2026 at 14:46, 52 minutes ago

    Edison issues report on HgT (HGT)

View all EQS
Les Echos
  • Published on 03/13/2026 at 07:30, 8 hours 8 minutes ago

    BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE

  • Published on 03/13/2026 at 07:30, 8 hours 8 minutes ago

    BIOPHYTIS PRÉSENTE SES PROGRAMMES DE DÉVELOPPEMENT DANS L’OBÉSITÉ ET LA SARCOPÉNIE AU CONGRÈS ICFSR

  • Published on 03/12/2026 at 18:30, 21 hours 8 minutes ago

    ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

  • Published on 03/12/2026 at 18:30, 21 hours 8 minutes ago

    ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

  • Published on 03/12/2026 at 18:30, 21 hours 8 minutes ago

    ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES FÉVRIER 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy